Clinical trial
Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study
NCT01385319 is registered in ClinicalTrials.gov with Marco Valgimigli as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study
- Lead sponsor
- Marco Valgimigli
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- June 30, 2011
- Completion date
- December 31, 2017
- Enrollment
- 1,606 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.